Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Malin Graffner-Nordberg"'
Publikováno v:
Chemical and Pharmaceutical Bulletin. 46:591-601
One way to minimise systemic side effects of drugs is to design molecules, soft drugs, in such a way that they are metabolically inactivated rapidly after having acted on their pharmacological target. Hydrolases (esterases, peptidases, lipases, glyco
Publikováno v:
ChemInform. 29
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 22(1)
A series of dihydrofolate reductase (DHFR) inhibitors, where the methylenamino-bridge of non-classical inhibitors was replaced with an ester function, have been prepared as potential soft drugs intended for inhalation against Pneumocystis carinii pne
Publikováno v:
Journal of medicinal chemistry. 46(16)
Crohn's disease is a chronic inflammatory bowel disease characterized by inflammation of both the small and large intestines. Methotrexate (MTX), a classical dihydrofolate reductase (DHFR) inhibitor, has been used as a therapeutic agent in the treatm
Publikováno v:
Journal of medicinal chemistry. 44(15)
A series of lipophilic soft drugs structurally related to the nonclassical dihydrofolate reductase (DHFR) inhibitors trimetrexate and piritrexim have been designed, synthesized, and evaluated in DHFR assays, with special emphasis on the inhibition of
Autor:
Göte Swedberg, Anders Hallberg, John Marelius, Asa Persson, Sofie Ohlsson, Paul Andersson, Malin Graffner-Nordberg, Johan Åqvist, Sven Andersson
Publikováno v:
Journal of medicinal chemistry. 43(21)
The relative binding affinities to human dihydrofolate reductase of four new potential antifolates, containing ester linkages between the two aromatic systems, were estimated by free energy perturbation simulations. The ester analogue, predicted to e